Alternatively, it is possible that neither genetic predisposition nor Alpha-2-macroglobulin quantity contribute towards the pathology of Alzheimer's disease, but rather differences in post-translational modification of this protein. The gene discussed is A2M; the disease is Alzheimer disease.